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Abstract
Background: Serum urea level is a heritable trait, commonly 
used as a diagnostic marker for kidney function. Genome-
wide association studies (GWAS) in East-Asian populations 
identified a number of genetic loci related to serum urea, 
however there is a paucity of data for European populations. 
Methods: We performed a two-stage meta-analysis of 
GWASs on serum urea in 13,312 participants, with indepen-
dent replication in 7,379 participants of European ancestry. 
Results: We identified 6 genome-wide significant single nu-
cleotide polymorphisms (SNPs) in or near 6 loci, of which 2 
were novel (POU2AF1 and ADAMTS9-AS2). Replication of 
East-Asian and Scottish data provided evidence for an addi-
tional 8 loci. SNPs tag regions previously associated with an-
thropometric traits, serum magnesium, and urinary albu-
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min-to-creatinine ratio, as well as expression quantitative 
trait loci for genes preferentially expressed in kidney and 
gastro-intestinal tissues. Conclusions: Our findings provide 
insights into the genetic underpinnings of urea metabolism, 
with potential relevance to kidney function.
© 2019 The Author(s) 
Published by S. Karger AG, Basel
Background
Serum urea is a diagnostic marker of renal function, 
widely used in clinical practice. Urea is eliminated by the 
kidneys into urine as waste product of protein metabo-
lism. The net serum urea concentration, therefore, re-
flects the excretory capacity of the kidney and elevated 
values are interpreted as reduced kidney function. Serum 
urea (or blood urea nitrogen, BUN, when only the nitro-
gen part is assayed), along with creatinine, is the most 
frequently requested measurement of kidney function in 
the assessment of patients with kidney disease. These 
2 markers are not equivalent in the estimation of kidney 
function, and in some conditions (peritoneal dialysis, 
heart failure) serum urea is considered to be superior to 
creatinine [1–3]. Alternatively to single-marker use, urea-
to-creatinine (or BUN-to-creatinine, respectively) ratio 
can be used for differential diagnosis of acute kidney in-
jury (prerenal, postrenal, or renal) when one marker is 
disproportionally elevated or lowered relative to the oth-
er [4–6].
Serum urea concentration is highly variable (reference 
range 1.8–7.1 mmol/L), and besides kidney function, it 
also depends on hydration status, metabolic rate, dietary 
protein intake, medication use, liver, and cardiac func-
tion [5, 6]. Genetic factors may also play a role: one twin 
study estimated heritability for serum urea concentra-
tion to be 44% [7], indicating a contribution of genetic 
factors to the inter-individual variability of this measure. 
Furthermore, genome-wide association studies (GWASs) 
on BUN in East-Asians reported single nucleotide poly-
morphisms (SNP) associations at 13 loci [8–11]. For 
 Europeans, there is paucity of data. A recent single-co-
hort study in the UK did not find any significant associa-
tions with urea levels [12], while in a Scottish single-co-
hort study (n = 19,293), 5 genetic variants were associated 
with urea [13]. These findings are yet to be replicated in 
other European cohorts. Concurrently, multiple GWASs 
in individuals of European descent identified a number 
of loci associated with serum creatinine and creatinine-
based indices of kidney function [14–18]. The genetics 
underlying urea and creatinine are expected to overlap, 
because, to a large extent, the serum concentration of 
both are influenced by kidney function. The studies in 
East-Asians confirm this notion as they reported 
MPPED2-DCDC5 to be associated with both urea and 
creatinine [10], thus suggesting the involvement of this 
gene with regulation of kidney function. Furthermore, 
family data from the UK show a positive genetic correla-
tion between urea and creatinine (rg = 0.56) [12]. The ex-
istence of exclusively urea-associated loci is also plausible, 
given that serum levels are not just dependent on kidney 
function. Identifying these loci will help explain a propor-
tion of kidney function-independent inter-individual 
variability in urea levels in the general population and 
ultimately will provide insight into pathways and regulat-
ing mechanisms involved in this metabolic compound. 
We therefore aimed to identify genetic loci influencing 
serum urea concentrations in populations of European 
ancestry. In addition, we compared our results with pre-
vious findings from East-Asian and Scottish studies to 
identify shared loci for serum urea.
Methods
Study Design
An overview of the study design is provided in Figure 1. Our 
strategy consisted of a number of steps. First, we performed a 
2-stage meta-analysis of GWAS to identify SNPs associated with 
serum urea. Second, we performed a replication study of loci iden-
tified in previous GWAS in East-Asian and Scottish populations. 
Third, we examined whether known eGFRcrea loci were also as-
sociated with serum urea. Furthermore, we conducted bioinfor-
matics follow-up analyses on identified SNPs to identify candidate 
loci. Each step is detailed below.
Study Population
Stage I discovery analyses were performed in 13,312 sub-
jects from the Lifelines Cohort Study. Stage II replication testing 
was performed in 7,379 subjects from the PREVEND (n = 3,387), 
NESDA (n = 2,523), EGCUT1 (n = 712), and EGCUT2 (n = 757) 
cohorts (online suppl. Note 1; for all online suppl. material, see 
www.karger.com/doi/10.1159/496930).
The Lifelines Cohort Study is a multidisciplinary prospective 
population-based cohort study with a unique 3-generation design 
that examines health and health-related behavior of 165,729 par-
ticipants living in the north-eastern region of the Netherlands 
(https://www.lifelines.nl/researcher). Participants were recruited 
from November 2006 to December 2013. Eligible individuals were 
invited through their general practitioner or through participating 
family members. Additionally, there was the option to self-regis-
ter. The recruitment and data collection, as well as the representa-
tiveness of the data have been described in detail elsewhere [19, 
20]. Of the 165,729 participants, 15,368 presumably unrelated, old-
est members of their respective families, were genotyped (details 
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below). The Lifelines Cohort Study was conducted according to 
the guidelines in the Declaration of Helsinki, and all procedures 
involving human subjects were approved by the Medical Ethics 
Committee of the University Medical Center Groningen. Written 
informed consent was obtained from all participants during their 
visit to one of the research centers. 
Genotyping, Quality Control, and Imputation
A total of 15,368 individuals of the Lifelines Cohort Study were 
genotyped using the Illumina HumanCytoSNP-12 array and called 
using GenomeStudio (San Diego, CA, USA). Only autosomal 
SNPs were used in this study. SNPs were excluded when the call 
rate was < 95%, when the minor allele frequency was < 1%, or when 
the p value of the Hardy-Weinberg equilibrium test was < 10–6. 
Samples were removed when the call rate was < 95%, when there 
was a sex mismatch between database and genotypes, when the 
heterozygosity deviated > 4 SD from the mean heterozygosity over 
all samples, when it was a first-degree relative to a sample that had 
a higher call rate, or when non-Caucasian ancestry was likely. After 
quality control, a total of 268,407 SNPs and 13,385 samples re-
mained. The resulting dataset was phased using MACH [21] and 
imputed using Minimac [22] with the HapMap Phase 2 CEU 
 haplotypes [23] as reference set. SNPs with an imputation quality 
r2 < 0.3 or a minor allele frequency < 1% were excluded after impu-
tation. The resulting number of SNPs available for analysis was 
1.99 × 106. The procedure for genotyping, quality control, and im-
putation of the replication cohorts is described in online supple-
mentary Note S1. 
GWAS stage I: discovery
(Lifelines)
GWAS stage II: replication
(NESDA, PREVEND, EGCUT1+2)
Replication stage I + II cohorts
(Lifelines, NESDA, PREVEND,
EGCUT1+2)
Associations with serum urea in stage I + II
cohorts






















































14 loci associated with serum urea in European populations
14 kidney function loci
suggested to influence
serum urea
Fig. 1. Design and results of the present study. Genetic loci in GREY typefont indicate that these loci overlap between GWAS studies on 
serum urea/BUN.
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Phenotype Measurement in Lifelines
During the baseline examination, the study participants were 
asked to fill in a questionnaire before the visit. During the visit, a 
number of investigations were conducted and blood and 24 h-
urine samples were taken. A total of 13,385 genotyped participants 
were included in the present study. The final number of individu-
als analyzed for serum urea was 13,312 after excluding subjects 
with extreme values of urea deviating > 4 SDs from the mean. Se-
rum urea measurements were performed with an ultraviolet ki-
netic assay on a Roche Modular. Serum creatinine was measured 
using an enzymatic method, IDMS traceable on a Roche Modular 
(Roche, Mannheim, Germany). We estimated eGFRcrea with the 
4-variable Modification of Diet in Renal Disease Study equation 
[24]. Body mass index (kg/m2) was calculated by dividing the 
weight (kg) by squared height (m2). 
Statistical Analysis
Three GWASs on serum urea were performed. In the first 
GWAS, a linear regression for each SNP was performed using 
an additive SNP model adjusting for age, age2, sex, body mass 
index, and the first 10 principal components to adjust for pop-
ulation stratification using PLINK [25]. In the second GWAS, 
log10-transformed eGFRcrea, was added to the model. In a third 
GWAS, we adjusted for serum creatinine instead of logeGFR-
crea. In addition to these 3 GWAS, we performed sex-stratified 
analyses. Next, the GWAS results were checked for quality us-
ing the  QCGWAS  package in R [26]. For each GWAS, sugges-
tive SNPs (p value < 10–6 in Stage I analyses) were clumped for 
linkage disequilibrium (LD; r2 > 0.1) using pairwise LD check-
ing in SNAP [27] to identify independent index SNPs. These 
suggestive index SNPs were taken forward to Stage II replica-
tion.
The same linear regression analyses, as described above, were 
applied to the suggestive SNPs identified in the discovery sample 
in each of the 4 replication cohorts separately. The replication re-
sults of these SNPs were meta-analyzed using an inverse variance 
weighted fixed-effects meta-analysis as implemented in the soft-
ware package GWAMA [28]. A SNP was considered replicated 
with a one-sided p value < 0.05 (i.e., same direction of effect), and 
with significance at the genome-wide level in the combined Stage 
I + II samples (p < 5 × 10–8). 
Finally, we also sought to replicate 20 SNPs at 13 genetic loci 
previously identified in GWASs of East-Asian samples [8–11], as 
well as 5 SNPs at 5 loci identified in a Scottish sample [13]. The 
replication results of these 25 SNPs were meta-analyzed using an 
inverse variance fixed-effects meta-analysis as implemented in the 
software package GWAMA [28]. We used all 5 cohorts (i.e., Life-
lines, NESDA, PREVEND, EGCUT1 + 2) for these analyses. We 
considered a SNP replicated at a one-sided p < 0.05. 
Associations with Kidney Function
We meta-analyzed associations of 53 known kidney function 
SNPs [17] with serum urea in all Stage I + II cohorts. Conversely, 
to examine associations of our 6 index SNPs with kidney function, 
we searched publicly available summary data from the same meta-
analysis of GWAS on eGFRcrea [17]. At a one-sided p < 0.05, we 
tested whether variants genome-wide significantly associated with 
lower eGFRcrea were associated with higher urea, and whether 
SNPs genome-wide significantly associated with higher urea were 
associated with lower eGFRcrea. 
Proportion of Phenotypic Variance Explained
We estimated the proportion of phenotypic variance, explained 
in the NESDA cohort, by regressing serum urea level on a weight-
ed genetic risk score (GRS) comprising the effects of all 6 index 
SNPs, of the 6 index SNPs +11 independent SNPs from the Scottish 
and East-Asian studies, and of the 53 eGFRcrea SNPs. These anal-
yses were performed using PLINK [25] and R [29] on independent 
SNPs (https://ldlink.nci.nih.gov/) using the effect sizes from the 
discovery sample (our 6 index SNPs) or from literature as weights.
Bioinformatics Characterization of the Replicated SNPs 
We examined the functionality (i.e., non-synonymous SNPs 
and expression quantitative trait loci, eQTL) of the identified in-
dex SNPs. To this end, we first converted the positions of all rep-
licated index SNPs to NCBI build 37. We then used the 1,000 
Genomes Project phase3 release [30] of variant calls to find proxy 
SNPs in moderate (r2 > 0.5) and high LD (r2 > 0.8) with our index 
SNPs. This dataset is based on the 2013-05-02 sequence freeze 
and alignments. We used version 5a (February 20, 2015), includ-
ing the 503 subjects of European ancestry. We used ANNOVAR 
(version July 16, 2017; http://annovar.openbioinformatics.org/) 
[31] for annotation of the index SNPs. We queried PolyPhen-2 
(http://genetics.bwh.harvard.edu/pph2/) [32] to assess whether 
effects of non-synonymous SNPs were predicted to be malignant. 
Furthermore, we performed a lookup of the index and proxy 
SNPs in the GWAS catalog [33] to ascertain whether these SNPs 
were previously associated with other phenotypes. Genes close to 
the 6 index SNPs were followed up for local expression (ciseQTL) 
in various tissues based on publicly available transcriptomics 
data: Human Protein Atlas (www.proteinatlas.org/) [34], GTEx 
Portal (https://www.gtexportal.org/) [35], and blood tissue 
(https://genenetwork.nl/bloodeqtlbrowser/) [36]. Furthermore, 
we examined eQTLs in donor kidney tissue in TransplantLines 
(detailed description of data and methods in online suppl. Note 
11) [37, 38]. 
Results
Meta-Analysis Results
Manhattan plots of stage I for models 1 and 2 are 
shown in online supplementary Figure 2a. Regional as-
sociation plots, showing location and significance of top 
hits for models 1 and 2 relative to known loci, are shown 
in online supplementary Figure S3. Risk of bias due to 
population stratification was assessed and considered ac-
ceptable (λ = 1.05; online suppl. Fig. S4). For models 1 and 
2, 7 index SNPs were at least suggestive (p < 1 × 10–6) in 
stage I. Of these 7 SNPs, rs17586946 on chromosome 6 
was only suggestive in the combined Stage I + II samples 
(p = 1.4 × 10–7) and hence not replicated. Table 1 shows 
results of the remaining 6 SNPs. For model 1, we repli-
cated 3 SNPs (rs914615, rs4686914, rs2003313) at 3 ge-
nomic loci, significantly associated with serum urea at 
the  genome-wide level (p < 5 × 10–8) in the combined 
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Stage I + II samples. In the second, logeGFRcrea-adjusted 
model, 2 SNPs from model 1 (rs4686914 and rs2003313) 
were again identified, while in addition 3 other SNPs 
(rs998394, rs11954639, rs2503107) were identified 
and replicated with genome-wide level significance. One 
SNP (rs914615) did not reach suggestive significance of 
p < 1 × 10–6 after logeGFRcrea adjustment (p = 2.9 × 10–6) 
and therefore was deemed non-significant for this model. 
A third, serum creatinine adjusted model, yielded essen-
tially the same results as the logeGFRcrea-adjusted model 
(online suppl. Fig. 2a and Table S5). 
Sex-stratified analysis yielded no additional loci: (1) 
we found no significant associations in female-only mod-
els, and (2) in male-only models, we identified 2  additional 
SNPs (rs9860469 and rs9820812) in high LD (r2 = 0.70 
and r2 = 1.0, respectively) with a SNP already identified in 
models 1–2 (rs4686914; online suppl. Fig. S2b). Effects of 
rs4686914 and rs11954639 were stronger in men (online 
suppl. Table S6).
Replication of Previously Reported Urea Loci
We replicated 10 out of 13 East-Asian loci [8–11] at a 
one-sided p < 0.05 (online suppl. Table S7a). SNPs at 3 
loci (MECOM, C12orf51, GNAS) were not replicated in 
the present study. All 5 Scottish loci [13] were replicated 
(online suppl. Table S7b). In total, 14 loci are now con-
firmed for Europeans (Fig. 2). 
Associations with Kidney Function
One index SNP (rs2003313) was significantly associ-
ated with kidney function, though not in the expected 
direction (online suppl. Fig. S8a and Table S8b). rs914615 
and rs2503107 were borderline significantly associated 
with kidney function (p = 0.095 and p = 0.085) in the ex-
pected direction. Conversely, 53 known eGFRcrea SNPs 
[17] were examined for potential associations with serum 
urea levels in all Stage I + II cohorts. After meta-analysis, 
14 of the 53 SNPs were significantly associated with se-
rum urea levels (online suppl. Fig. S9a and Tables S9b-c), 
more than could be expected through random chance 
alone (binomial distribution, 14/53, α = 0.05, p = 1.98 × 
10–7).
Proportion of Phenotypic Variance Explained in the 
NESDA Cohort
A GRS comprising all 6 index SNPs explained a small, 
but significant proportion of 0.43–0.45% of phenotypic 
variation in NESDA (online suppl. Table S10). This in-
creased to 0.45–0.56% when 11 independent SNPs were 
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ed GRS comprised of all 17 SNPs showed a modest but 
significant linear trend (p < 2.3 × 10–4) in urea levels 
(Fig. 3). However, we observed no clinically relevant dif-
ferences in serum urea between extremes of this GRS. The 
53 SNPs identified to be associated with serum creatinine 
by the CKDGen consortium explained 0.18% of the vari-
ance in serum urea (p = 0.02), but significance of this ef-
fect disappeared when correcting for logeGFRcrea or se-
rum creatinine.
Bioinformatics Characterization of the Index SNPs
Our analyses returned 345 SNPs in at least moderate 
LD (r2 > 0.50), of which 173 in at least high LD (r2 > 0.80) 
and 49 in perfect LD (r2 = 1). rs914615 is linked with 2 
non-synonymous SNPs: rs760077 (MTX1) and rs4745 
(EFNA1), both of which are predicted to be benign [32]. 
A number of proxy SNPs in high LD (r2 > 0.8) with index 
SNPs were reported in the literature as associated with 
other kidney function or metabolically relevant traits, 
such as serum magnesium level and anthropomorphic 
traits. rs914615 was previously found to be associated 
with urinary albumin-to-creatinine ratio in diabetic sub-
jects [39] (online suppl. Table S13). Using eQTL data 
publicly available from GTEx Portal, we found associa-
tions of 3 SNPs with gene expression in various tissues, 
and predominantly in gastro-intestinal tissues (online 
suppl. Table S14): rs914615 with expression of numerous 
genes, among others EFNA1, MTX1, MUC1, and THBS3; 
rs2003313 with COLCA1 and COLCA2; and rs11954639 
with RPL37. In whole blood, SNP rs914615 was associ-
ated with expression of THBS3, ADAM15, KRTCAP2 
(online suppl. Table S15). In kidney biopsy specimens, we 
found an association of the A allele of rs914615 with de-
























Fig. 2. Overview of all 17 currently identified loci in European and East-Asian populations. Overlap indicates replication in present study. 
The 6 BOLD loci are genome-wide significant (p < 5 × 10–8) in the present study; all other loci in overlapping areas were replicated in 
the present study at a one-sided p < 0.05. * Novel loci for European populations.
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Discussion
In this meta-analysis of GWAS in European popula-
tions, we identified 6 index SNPs at 6 genomic loci (in 
THBS3, ADAMTS9-AS2, RSPO3, or near LPP, PTGER4, 
and POU2AF1) that were associated with serum urea lev-
els at a genome-wide significant level. Of these 6 index 
SNPs, 2 (near POU2AF1 and in ADAMTS9-AS2) are 
completely novel associations with urea, that is, not previ-
ously identified in either the East-Asian or Scottish stud-
ies. Three SNPs tag regions (THBS3, LPP, and RSPO3) 
previously identified in East-Asians. SNP rs11954639 
near PTGER4 is in high LD with a SNP previously identi-
fied in Scottish GWAS. Follow-up analysis of the 6 index 
SNPs yielded potential roles of a number of loci in urea 
metabolism.
In addition to our main meta-analysis, we examined 
20 SNPs at 13 genetic loci previously associated with BUN 
in East-Asians [8–11]. Of these 20 SNPs, we replicated 15 
at a one-sided p < 0.05, confirming 10 previously identi-
fied loci (MTX1-GBA, PAX8, BCL6-LPP, LRIG1-KBT-
BD8, RSPO3, UNCX, MPPED-DCDC5, WDR72, BCAS3, 
and SLC14A2) but not MECOM, C12orf51, and GNAS. Of 
note, we replicated SNPs at the SLC14A2 locus, a gene 
that encodes a renal tubular urea transporter (RefSeq re-
lease 89) [40]. Furthermore, we confirmed SNP associa-
tions at MTX1, RP11–115 J16.1, PRKAG2, UNCX, and an 
intergenic region near PTGER4, that were identified in a 
single-cohort GWAS in 19,293 Generation Scotland par-
ticipants [13]. After replication, SNPs at 14 loci now have 
confirmed associations with serum urea in Europeans. 
SNPs tagging PTGER4, PRKAG2, ADAMTS9-AS2, and 
POU2AF1 were specific to European studies, likely due to 
considerably lower minor allele frequencies in East-
Asians (0, 0, 16, and 12%, respectively) compared with 
Europeans (7, 30, 46, and 44%) according to the 1000G 
phase 3 East-Asian and European reference sets [30].
GWAS of biomarkers that are excreted through the 
kidney may be confounded by kidney function [41]. We 
therefore examined the effect of kidney function on SNP 
associations by running both unadjusted models and lo-
geGFRcrea-adjusted models. Associations of 2 SNPs 
(rs4686914, rs2003313) were unaffected by this adjust-



















































































Weighted genetic risk score
(standard deviations from mean)
Fig. 3. Boxplots of serum urea levels 
(mmol/L) by categories of a weighted GRS 
comprised of all 17 currently identified se-
rum urea SNPs in the NESDA cohort (n = 
2,472). The black dots represent the medi-
ans, the grey boxes represent the observa-
tions between the 25th and the 75th per-
centile, the whiskers represent (at maxi-
mum) 1.5 times the interquartile range, the 
notches represent the 95% CI of the medi-
an. In the rightmost boxplot, the notches 
extend to outside the box due to its wide 
95% CI. The underlying light grey histo-
gram represents the population distribu-
tion of the GRS; its bell shape approximates 
a normal distribution. The dashed hori-
zontal line depicts the median serum urea 
level in the NESDA cohort (4.8 mmol/L). 
GRS, genetic risk score.
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through kidney function but through other mechanisms. 
Associations of 3 SNPs (rs998394, rs11954639, rs2503107) 
were only significant in the logeGFRcrea-adjusted model, 
indicating positive confounding/suppression, that is, ge-
netic effects were masked by kidney function. Associa-
tions of one SNP (rs914615) diminished after logeGFR-
crea adjustment, suggesting that the effect of this SNP on 
serum urea is (partly) confounded or mediated through 
kidney function. In the following paragraphs, we discuss 
the 2 novel loci. 
We report a novel association of urea with rs2003313, 
a SNP on chromosome 11 in an intergenic region near 
POU2AF1. We queried the GWAS catalog to find oth-
er phenotypes associated with this SNP, and SNPs in LD, 
r2 > 0.50); however, we found none. eQTL analysis in 
GTEx [35] yielded significant associations of rs2003313 
with expression of COLCA2 and COLCA1 (aliases 
C11orf93 and C11orf92, respectively) in colon, esopha-
gus, spleen, tibial artery and nerve, and adipose tissue. 
Protein function of COLCA2 is currently unknown. 
COLCA1 encodes a transmembrane protein of granular 
structures, such as crystalloid eosinophilic granules and 
other granular organelles [40], with preferential expres-
sion in stomach, urinary bladder, and prostate [34]. 
Both COLCA2 and COLCA1 have previously been asso-
ciated to colorectal cancer [42]. Relevance of this locus 
to serum urea is unclear, and may be explored in future 
study. Against expectations, the T allele of rs2003313 
was associated with lower serum urea in the present 
study, and with lower eGFRcrea in CKDGen data [17]. 
Whether this is due to unmeasured confounding or 
some unknown biological factor may be explored in fu-
ture study. Of note, moderate heterogeneity was ob-
served (I2: 43–61%) with diminution of effect size in the 
replication phase, possibly indicative of Winner’s curse 
[43], that is, the effect of this SNP may be overestimated. 
Nonetheless, the strong significance of the combined 
meta-analysis of this locus indicates that it is a non-spu-
rious signal.
A second novel SNP is rs998394 on chromosome 3. 
Although in relative proximity (distance ∼2Mb) to SNPs 
(near LRIG1-KBTBD8) previously identified in East-
Asian GWAS on BUN, these are not in LD (r2 = 0.0); we 
thus consider this SNP as independent and therefore a 
novel finding. rs998394 is located in ADAMTS9-AS2, a 
long non-coding RNA that is an antisense transcript of 
ADAMTS9. The protein encoded by ADAMTS9 is a 
member of the ADAMTS (a disintegrin and metallopro-
teinase with thrombospondin motifs) protein family. 
Members of this family have been implicated in the cleav-
age of proteoglycans, the control of organ shape during 
development, and the inhibition of proteoglycans [40]. 
ADAMTS9 is localized to chromosome region 3p14.3-
p14.2, an area known to be lost in hereditary renal tumors 
[44]. ADAMTS9 has previously been associated with an-
thropomorphic traits [45, 46] and type 2 diabetes mellitus 
[47]. 
Loci tagged by the other 4 index SNPs are discussed in 
online supplementary Note S12. Briefly, we found poten-
tial roles of MUC1 and PTGER4 in urea metabolism and/
or kidney function. 
Sex-stratified analysis yielded no additional loci, al-
though a marked difference in effect size was observed 
between men and women for rs4686914 and rs11954639. 
This is suggestive of gender-specific mechanisms of urea 
metabolism which may be investigated in future study.
Fourteen out of 53 (26%) known eGFRcrea loci were 
associated (one-sided p < 0.05) with serum urea levels in 
our discovery cohort, more than could be expected 
through random chance alone. Furthermore, a GRS based 
on these loci was modestly but significantly associated 
with serum urea, supporting the notion of genetic overlap 
between the 2 traits. Previously, Okada et al. [10] ob-
served associations of MPPED-DCDC5, BCAS3, WDR72, 
and UNCX with both creatinine and BUN at the genome-
wide level in East-Asians, indicating possible pleiotropy. 
In addition, the present study suggests pleiotropy for 
PRKAG2, UNCX, and WDR72, given that these known 
eGFRcrea loci are also associated with serum urea in the 
present study. 
To the best of our knowledge, the present study is the 
first meta-analysis of GWAS of serum urea in European 
populations. We were able to report new associations for 
European populations and confirm known associations 
from East-Asian studies. However, a GRS combining all 
currently identified SNPs was only modestly associated 
with serum urea. Future study may involve imputation 
to the Haplotype Reference Consortium reference set 
[48], which due to its higher resolution may yield more 
precise results. Given the estimated explained variance of 
the identified SNPs (0.56%), and the estimated heritabil-
ity of serum urea levels (44%), many of the genetic fac-
tors influencing serum urea are still to be found; larger 
samples are needed to detect these factors. Consequent-
ly, the immediate clinical relevance of our findings is 
limited. 
In conclusion, we report the first meta-analysis of 
GWAS of serum urea levels in European populations. We 
identified 6 genomic loci reproducibly associated with se-
rum urea. We are the first to report 2 SNP associations 
GWAS of Serum Urea 201Am J Nephrol 2019;49:193–202
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with urea near POU2AF1 and in ADAMTS9-AS2. The 
identified regions have possible relevance to urea metab-
olism, as well as kidney function.
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